Fact CheckerSign in

NCT06687408Recruiting

Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques

Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques: a Multicenter Cohort Study

Source: ClinicalTrials.gov · Last updated 24 Apr 2026

Brief summary (registry, in English)

The goal of this multicenter observational study is to evaluate the long-term survival and perioperative outcomes of sleeve lobectomy in robotic-assisted thoracic surgery (RATS) for patients with central lung cancer when compared with video-assisted thoracic surgery (VATS) approach, both of which have been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently. The main question it aims to answer is: Are RATS sleeve lobectomy associated with similar or even better long-term survival and perioperative outcomes for patients with central lung cancer when compared with the VATS approach?

Status (registry)
Recruiting
Study type
Observational
Enrollment
450 (estimated)
First submitted
8 Nov 2024
Start date
1 Mar 2025
Primary completion date
31 Dec 2027
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Diseases
Lung cancer
NCT number
NCT06687408

What you commit to

  • Study type: Observational
  • Planned participants: 450
  • From 1 Mar 2025 to the primary completion date, 31 Dec 2027
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Unable to undergo surgical resection due to surgical contraindications;

Other illness

  • Postoperative pathology does not confirm non-small cell lung cancer (NSCLC), including but not limited to benign lesions, small cell lung cancer, metastatic tumors, or an insufficient or indeterminate histopathology report;
  • History of malignancy within the past 5 years;

Other

  • Unable to obtain follow-up data;
  • Refusal to sign the informed consent or withdrawal of consent.

Who the study is looking for

  • Age ≥ 18 years;
  • Clinically suspected lung cancer with a high likelihood of undergoing sleeve lobectomy;
  • Postoperative histopathological diagnosis confirms non-small cell lung cancer (NSCLC);
  • No history of malignancy within the past 5 years;
  • Signed informed consent agreeing to participate in this study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sir Run Run Shaw Hospital, Medical College, Zhejiang University
Coordinator of this site? Confirm its status
HangzhouChinaRecruiting
The Second Affiliated Hospital Zhejiang University School of Medicine
Coordinator of this site? Confirm its status
HangzhouChinaRecruiting
Shanghai Chest Hospital, Shanghai Jiao Tong University
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.